Michael Lunn to Humans
This is a "connection" page, showing publications Michael Lunn has written about Humans.
Connection Strength
0.083
-
Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 06 22; 144(5):e47.
Score: 0.008
-
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2021 03 03; 144(2):682-693.
Score: 0.007
-
COVID-19 vaccine and Guillain-Barré syndrome: let's not leap to associations. Brain. 2021 03 03; 144(2):357-360.
Score: 0.007
-
Laboratory biomarkers associated with COVID-19 severity and management. Clin Immunol. 2020 12; 221:108614.
Score: 0.007
-
A case of limbic encephalitis associated with asymptomatic COVID-19 infection. J Neurol Neurosurg Psychiatry. 2020 11; 91(11):1229-1230.
Score: 0.007
-
Neurology in the time of COVID-19. J Neurol Neurosurg Psychiatry. 2020 06; 91(6):568-570.
Score: 0.007
-
Advances in POEMS treatment and the need to define standardised outcome measures. Br J Haematol. 2019 04; 185(2):386-388.
Score: 0.006
-
POEMS syndrome. Curr Opin Neurol. 2018 10; 31(5):551-558.
Score: 0.006
-
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment. Eur J Neurol. 2018 11; 25(11):1384-1388.
Score: 0.006
-
Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel. Br J Haematol. 2017 03; 176(5):728-742.
Score: 0.006
-
Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort. Br J Anaesth. 2021 08; 127(2):e75-e78.
Score: 0.002
-
Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe? Brain. 2020 12 01; 143(12):e101.
Score: 0.002
-
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020 10 01; 143(10):3104-3120.
Score: 0.002
-
High-dose therapy and autologous transplantation for POEMS Syndrome: effective, but how to optimise? Br J Haematol. 2019 09; 186(6):e178-e181.
Score: 0.002
-
Prevalence and Course of Endocrinopathy in POEMS Syndrome. J Clin Endocrinol Metab. 2019 06 01; 104(6):2140-2146.
Score: 0.002
-
[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinemia. Haematologica. 2018 07; 103(7):e322-e324.
Score: 0.002
-
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimers Res Ther. 2018 03 20; 10(1):32.
Score: 0.002
-
High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy. J Neurol Neurosurg Psychiatry. 2018 09; 89(9):1007-1009.
Score: 0.001
-
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-ß Concentration. J Alzheimers Dis. 2017; 56(3):885-891.
Score: 0.001